• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

NVIDIA and Eli Lilly Launch AI Co-Innovation Lab to Reinvent Drug Discovery

by Fred Pennic 01/12/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
NVIDIA and Eli Lilly Launch AI Co-Innovation Lab to Reinvent Drug Discovery

What You Should Know

– NVIDIA and Eli Lilly and Company have announced a historic $1B, five-year investment to launch an AI co-innovation lab in the San Francisco Bay Area.

– Utilizing the NVIDIA BioNeMo platform and the next-generation Vera Rubin architecture, the lab will co-locate top AI engineers with biology experts to build a “continuous learning system” that integrates agentic wet labs with robotic manufacturing and physical AI.


The “Continuous Learning” Framework: Connecting Wet and Dry Labs

For decades, the “Valley of Death” in drug discovery has been the gap between computational predictions (dry labs) and experimental validation (wet labs). This collaboration aims to close that gap by creating a 24/7 AI-assisted experimentation loop.

  • Scientist-in-the-Loop: Agentic wet labs will generate massive, high-quality datasets that feed directly back into NVIDIA’s foundation models, allowing the AI to “learn” from every physical experiment in real-time.
  • BioNeMo as the Backbone: The lab will use NVIDIA BioNeMo™ as the critical platform to accelerate the development of next-generation frontier models for biology and chemistry.
  • The Vera Rubin Edge: The initiative intends to harness the NVIDIA Vera Rubin architecture—the most powerful computational framework in the industry—to train models with unprecedented speed and accuracy.

Physical AI and Robotics: Engineering the Supply Chain

The partnership extends beyond the microscope and into the factory. NVIDIA and Lilly are pioneering the use of Physical AI to secure and scale medicine production.

  • Digital Twins: Using NVIDIA Omniverse™ and RTX PRO™ Servers, Lilly will create digital twins of its manufacturing lines. This allows engineers to stress-test and optimize supply chains in a virtual environment before implementing physical changes.
  • Robotic Manufacturing: The “AI Factory” will utilize robotics to enhance the production capacity of high-demand medications, strengthening supply chain reliability against global disruptions.

“AI is transforming every industry, and its most profound impact will be in life sciences,” said Jensen Huang, founder and CEO of NVIDIA. “NVIDIA and Lilly are bringing together the best of our industries to invent a new blueprint for drug discovery — one where scientists can explore vast biological and chemical spaces in silico before a single molecule is made.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Drug Discovery

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |